Literature DB >> 31105820

Euscaphic acid inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.

Weibo Dai1, Pengpeng Dong2, Jing Liu3, Yuqiao Gao1, Ying Hu1, Hui Lin1, Ye Song1, Quanxi Mei1.   

Abstract

Rubus alceaefolius Poir. has been used for the treatment of nasopharyngeal carcinoma (NPC) in China for many years. Euscaphic acid is an active component of Rubus alceaefolius Poir. However, the mechanism of action of euscaphic acid in NPC remains unclear. In this study, Euscaphic acid inhibited the proliferation of NPC cells, induced apoptosis, and led to cell cycle arrest in the G1/S phase. In addition, euscaphic acid inhibited the expression of phosphatidylinositide 3-kinases (PI3K), phosphorylated protein kinase B (p-AKT), and phosphorylated mammalian target of rapamycin (p-mTOR) p-mTOR in NPC cells. The activation of the PI3K/AKT/mTOR signaling pathway by IGF-1 promoted cell proliferation, inhibited apoptosis, and cell cycle arrest in NPC cells. In conclusion, we demonstrated that euscaphic acid reduced cell proliferation and induced apoptosis and cell cycle arrest in NPC cells by suppressing the PI3K/AKT/mTOR signaling pathway.

Entities:  

Keywords:  AKT; Euscaphic acid; PI3K; mTOR; nasopharyngeal carcinoma

Year:  2019        PMID: 31105820      PMCID: PMC6511751     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  7 in total

1.  Inhibitory Effects of Euscaphic Acid in the Atopic Dermatitis Model by Reducing Skin Inflammation and Intense Pruritus.

Authors:  Na-Hee Jeong; Soyoung Lee; Young-Ae Choi; Kyung-Sik Song; Sang-Hyun Kim
Journal:  Inflammation       Date:  2022-03-07       Impact factor: 4.092

Review 2.  Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation.

Authors:  Jérôme Archambeau; Alice Blondel; Rémy Pedeux
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

3.  Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma.

Authors:  Bo Tu; Ling Ye; Qingsong Cao; Sisi Gong; Miaohua Jiang; Hui Li
Journal:  Hereditas       Date:  2022-01-08       Impact factor: 3.271

4.  YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma.

Authors:  Yuting Zhan; Xianyong Chen; Hongmei Zheng; Jiadi Luo; Yang Yang; Yue Ning; Haihua Wang; Yuting Zhang; Ming Zhou; Weiyuan Wang; Songqing Fan
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

5.  Comparative Assessment of the Antioxidant and Anticancer Activities of Plicosepalus acacia and Plicosepalus curviflorus: Metabolomic Profiling and In Silico Studies.

Authors:  Enas E Eltamany; Marwa S Goda; Mohamed S Nafie; Abdelghafar M Abu-Elsaoud; Rawan H Hareeri; Mohammed M Aldurdunji; Sameh S Elhady; Jihan M Badr; Nermeen A Eltahawy
Journal:  Antioxidants (Basel)       Date:  2022-06-25

6.  Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.

Authors:  Wei Li; Huiping Ma; Minglei Liu
Journal:  Mol Biotechnol       Date:  2021-07-08       Impact factor: 2.695

Review 7.  The Occurrence and Biological Activity of Tormentic Acid-A Review.

Authors:  Marta Olech; Wojciech Ziemichód; Natalia Nowacka-Jechalke
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.